IMMUNO-ONCOLOGY INSIGHTS

Leveraging cutting edge tools to convert I-O data into knowledge
Guest Editor:
Jacques Moisan, Translational Innovation Platform - Immuno-Oncology Scientific Site Head (USA) at EMD Serono, Inc
Jacques Moisan
Jacques Moisan
Translational Innovation Platform - Immuno-Oncology Scientific Site Head (USA) at EMD Serono, Inc
Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Overcoming purification challenges in antibody therapeutics manufacturing...

L Sierkstra,
Laurens Sierkstra
Laurens Sierkstra
Senior Director, Business Leader Purification, Thermo Fisher Scientific
8 September 2021
Innovator Insight
Yes, IMMUcan! Unraveling the human tumor microenvironment
Yes, IMMUcan! Unraveling the human tumor microenvironment
H Hong,
R Liechti,
M Morfouace
14 October 21
Commentary
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge
A Sood,
S Prabhakaran,
G Goldmacher et al.
12 October 21
Expert Roundtable
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge
A Sood,
S Prabhakaran,
G Goldmacher et al.
12 October 21
Expert Roundtable Video
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight
11 October 21
Innovator Insight
Cancer in 4D: the importance of spatial and temporal heterogeneity through breast cancer molecular cartography
Cancer in 4D: the importance of spatial and temporal heterogeneity through breast cancer molecular cartography
C Martinez
11 October 21
Commentary
The use of artificial intelligence in immuno-oncology drug discovery: are we closing the gap?
The use of artificial intelligence in immuno-oncology drug discovery: are we closing the gap?
C Boutton,
M Wendt
8 October 21
Expert Insight
View all

Enhancing preclinical predictivity

1 July 2021

Hunting for better biomarkers of response

1 June 2021

Modelling the I-O manufacturing facilities of tomorrow

1 April 2021

Understanding and overcoming mechanisms of tumor resistance

1 January 2021

Addressing lingering safety issues for I-O product candidates in development

8 December 2020

Next gen I-O approaches: what will follow the PD-1s?

27 November 2020
View all

  • Advancing engineered cell and gene therapy with precision gene editing
    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now

  • Enabling clinical grade manufacturing of gene-engineered NK cells
    N Moker,
    E Ullrich,
    R Romee et al.
    Nina Möker
    Nina Möker
    R&D Reagents Manager, Allogeneic Cell Therapy, Miltenyi Biotec
    Prof. Dr. Evelyn Ullrich
    Prof. Dr. Evelyn Ullrich
    Arbeitsgruppe Zelluläre Immunologie, Universitätsklinikum, Frankfurt am Main (kgu.de)
    Rizwan Romee, MD
    Rizwan Romee, MD
    Associate Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute
    Volker Huppert
    Volker Huppert
    Chief Development Officer Glycostem Therapeutics
    30 November 2021
    Watch now

  • Gain deeper insights into the mechanisms of immune cell killing of tumor cells:...
    C Souders,
    T Dale,
    N Bevan et al.
    Dr Colby Souders
    Dr Colby Souders
    Chief Scientific Officer, Abveris
    Tim Dale, PhD
    Tim Dale, PhD
    Head of BioAnalytics Applications, Sartorius
    Nicola Bevan
    Nicola Bevan
    Manager of Cell Imaging Applications, Sartorius
    Jeffrey Skolnik, M.D.
    Jeffrey Skolnik, M.D.
    Senior Vice President, Clinical Development, Inovio
    6 October 2021
    Watch now

  • The therapeutic gene editing solution – cell therapy for solid tumors
    B Sasu,
    P Sivakumar,
    J Trager et al.
    Barbra Sasu, PhD
    Barbra Sasu, PhD
    Chief Scientific Officer, Allogene Therapeutics
    Pallavur Sivakumar, PhD
    Pallavur Sivakumar, PhD
    Scientific Vice President and Head of Discovery, Immuno-Oncology and Cell Therapy Thematic Research Center, Bristol Myers Squibb
    James Trager, PhD
    James Trager, PhD
    Chief Scientific Officer, Nkarta Therapeutics
    Jennifer Harbottle, PhD
    Jennifer Harbottle, PhD
    Senior Scientist, R&D, Cell and Gene Therapy, Horizon Discovery
    30 September 2021
    Watch now

  • Get your non-viral T cell engineering process ready for clinical manufacturing
    M Rietenbach,
    S Wild,
    K Patel
    Melanie Rietenbach
    Melanie Rietenbach
    Global Product Manager Miltenyi Biotec
    Stefan Wild
    Stefan Wild
    Senior Manager, Research and Development, Miltenyi Biotec
    Kunal Patel
    Kunal Patel
    Process Engineering Manager, Miltenyi Biotec
    21 September 2021
    Watch now

  • Cell-based therapies for cancer treatment: leveraging advanced flow cytometry...
    N Senutovitch,
    R Fan,
    T Laskowski
    Nina Senutovitch Ph.D.
    Nina Senutovitch Ph.D.
    Senior Scientist, Product Development, Cell Imaging, Sartorius
    Professor Rong Fan
    Professor Rong Fan
    Professor of Biomedical Engineering, Yale University
    Tamara J. Laskowski, Ph.D.
    Tamara J. Laskowski, Ph.D.
    Scientific Project Director, Adoptive Cell Therapy Platform, Dept. of Stem Cell Transplantation and Cellular Therapy MD Anderson Cancer Center
    5 August 2021
    Watch now
    • View all

    Latest content

    Advancing engineered cell and gene therapy with precision gene editing
    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now
    Biomanufacturing I-O therapeutics in the 21st century

    Biomanufacturing I-O therapeutics in the 21st century

    G Zarbis-Papastoitsis,
    Gregory Zarbis-Papastoitsis
    Gregory Zarbis-Papastoitsis
    EVP of Process and Manufacturing Sciences, Ankyra Therapeutics
    29 November 2021
    Editorial
    Exploring the cutting edge in RNA-based cell line selection

    Exploring the cutting edge in RNA-based cell line selection

    S Sharfstein,
    S Tenenbaum,
    Susan Sharfstein
    Susan Sharfstein
    Professor of Nanobioscience, SUNY Polytechnic Institute, Albany, NY, USA
    Scott Tenenbaum
    Scott Tenenbaum
    Head of Nanobioscience, SUNY-Polytechnic Institute, Albany, NY, USA
    29 November 2021
    Interview
    Control of continuous processes for production of biopharmaceutical products

    Control of continuous processes for production of biopharmaceutical...

    A Rathore,
    S Nikita,
    Anurag Rathore
    Anurag Rathore
    Professor Department of Chemical Engineering, Indian Institute of Technology Delhi
    Saxena Nikita
    Saxena Nikita
    Research Associate Department of Chemical Engineering, Indian Institute of Technology Delhi
    29 November 2021
    Expert Insight
    Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

    Overcoming purification challenges in antibody therapeutics manufacturing...

    L Sierkstra,
    Laurens Sierkstra
    Laurens Sierkstra
    Senior Director, Business Leader Purification, Thermo Fisher Scientific
    8 September 2021
    Innovator Insight
    Yes, IMMUcan! Unraveling the human tumor microenvironment

    Yes, IMMUcan! Unraveling the human tumor microenvironment

    H Hong,
    R Liechti,
    M Morfouace
    Henoch Hong
    Henoch Hong
    at Merck KGaA
    Robin Liechti
    Robin Liechti
    at Swiss Institute of Bioinformatics
    Marie Morfouace
    Marie Morfouace
    14 October 2021
    Commentary
    Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge

    Expert Roundtable: leveraging cutting edge tools to convert I-O data...

    A Sood,
    S Prabhakaran,
    G Goldmacher et al.
    Anil K Sood
    Anil K Sood
    Professor, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center
    Sandhya Prabhakaran
    Sandhya Prabhakaran
    Applied Research Scientist, Integrated Mathematical Oncology Department, Moffitt Cancer Centre
    Gregory Goldmacher
    Gregory Goldmacher
    Executive Director, Clinical Research, Head of Clinical Imaging, Merck Research Laboratories
    Shomyseh Sanjabi
    Shomyseh Sanjabi
    Principal Scientist, Oncology Biomarker Development, Genentech
    12 October 2021
    Expert Roundtable Video
    Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge

    Expert Roundtable: leveraging cutting edge tools to convert I-O data...

    A Sood,
    S Prabhakaran,
    G Goldmacher et al.
    Anil K Sood
    Anil K Sood
    Professor, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center
    Sandhya Prabhakaran
    Sandhya Prabhakaran
    Applied Research Scientist, Integrated Mathematical Oncology Department, Moffitt Cancer Centre
    Gregory Goldmacher
    Gregory Goldmacher
    Executive Director, Clinical Research, Head of Clinical Imaging, Merck Research Laboratories
    Shomyseh Sanjabi
    Shomyseh Sanjabi
    Principal Scientist, Oncology Biomarker Development, Genentech
    12 October 2021
    Expert Roundtable
    Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

    Cell-based therapies for cancer treatment: leveraging advanced flow...

    11 October 2021
    Innovator Insight
    View all

    Latest News

    Allogene’s CAR T trials halted due to safety concerns

    Allogene’s CAR T trials halted due to safety concerns

    8 October 2021
    Intellia's NTLA-5001 receives green light for human testing

    Intellia's NTLA-5001 receives green light for human testing

    17 September 2021
    Designing a better CAR

    Designing a better CAR

    27 August 2021
    Regenerative medicine sector set for a record-breaking year

    Regenerative medicine sector set for a record-breaking year

    20 August 2021
    Terumo and PhotonPharma team up on cancer vaccine

    Terumo and PhotonPharma team up on cancer vaccine

    13 August 2021
    T-knife lands $110M and appoints new CSO

    T-knife lands $110M and appoints new CSO

    6 August 2021
    View all